Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any patterned macular dystrophy in which the cause of the disease is a mutation in the PRPH2 gene.
Features include always present findings: Pattern dystrophy of the retina; and very common findings: Yellow/white lesions of the retina. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Reticular retinal dystrophy, Macular dystrophy |
PRPH2 function has not been fully characterized.
Patterned macular dystrophy 1 is associated with mutations in the PRPH2 gene on chromosome 6.
Genetic testing for PRPH2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for patterned macular dystrophy 1 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 very common feature, 2 common features.
No clinical trials have been registered for patterned macular dystrophy 1.
206 publications have been identified in PubMed for patterned macular dystrophy 1. Kisho has analyzed 157 by research type. Research spans Epidemiology / Natural History (36%), Review / Meta-Analysis (16%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 57 | 36% |
Research summaries | 25 | 16% |
Laboratory research | 25 | 16% |
Clinical study results | 21 | 13% |
Testing and diagnosis research | 16 | 10% |
Patient case studies | 7 | 4% |
New treatment approaches | 6 | 4% |
Holz FG (2026). [PMID: 40967488](https://pubmed.ncbi.nlm.nih.gov/40967488/). *Ophthalmol Retina*. [Epidemiology / Natural History]
Romano F (2026). [PMID: 42135021](https://pubmed.ncbi.nlm.nih.gov/42135021/). *Br J Ophthalmol*. [Diagnostic / Biomarker]
Talks J (2026). [PMID: 41807615](https://pubmed.ncbi.nlm.nih.gov/41807615/). *Eye (Lond)*. [Epidemiology / Natural History]
Hussey KA (2026). [PMID: 41686445](https://pubmed.ncbi.nlm.nih.gov/41686445/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Bai ZP (2026). [PMID: 41211298](https://pubmed.ncbi.nlm.nih.gov/41211298/). *Ophthalmol Sci*. [Basic Science / Preclinical]
Lingardo S (2026). [PMID: 41385093](https://pubmed.ncbi.nlm.nih.gov/41385093/). *Graefes Arch Clin Exp Ophthalmol*. [Review / Meta-Analysis]
Hanhart J (2026). [PMID: 41913248](https://pubmed.ncbi.nlm.nih.gov/41913248/). *Int J Retina Vitreous*. [Review / Meta-Analysis]
Ciarmatori N (2026). [PMID: 41615526](https://pubmed.ncbi.nlm.nih.gov/41615526/). *Int Ophthalmol*. [Clinical Trial Publication]
Chen KY (2026). [PMID: 41482231](https://pubmed.ncbi.nlm.nih.gov/41482231/). *J Nutr*. [Review / Meta-Analysis]
Ly K (2026). [PMID: 42201956](https://pubmed.ncbi.nlm.nih.gov/42201956/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:25 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center